TCL Archive EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor. December 15, 2000
TCL Archive OMB Budget Revision Would Cut Centers $20 Million, Slash Clinical Education, Training, Contracts Funds April 22, 1983
TCL Archive FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says. April 1, 2005
TCL Archive NCAB To Hear Reports On Environmental Carcinogenesis, International Research Efforts June 4, 1976
